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ABSTRACT 
The invisible brain-heart link has been observed and described for centuries now, 
although a greater interest in the matter has been manifested over the past several 
decades, especially in patients with aneurysmal subarachnoid haemorrhage (aSAH). 
We present the case of a patient with aSAH and signs of cardiac injury evoked by ECG 
changes and elevated cardiac enzymes. Furthermore, we reviewed current medical 
literature by searching the international database PubMed for recent articles on the 
subject of cardiac biomarkers, ECG and echocardiography changes in the setting of 
SAH. Our analysis of the selected articles, published between 2012 and 2018, 
revealed that 22 are patient population studies, 16 are case studies and 6 are reviews 
of the literature. The most common ECG changes were prolonged QTc 
andnonspecific ST/T-wave changes. Echocardiography changes included regional 
wall-motion abnormalities, typically involving the base of the heart (neurogenic 
stunned myocardium), yet there was also the scenario of Takotsubo cardiomyopathy 
(stress cardiomyopathy), which affects the apex of the heart. There is a significant 
statistical association of elevated levels of troponin and NT-proBNP with a bad 
outcome after SAH, and we should always keep in mind the dramatic scenario of 
misdiagnosing the cerebral haemorrhage and treating for a coronary syndrome 
instead. Therefore, the management of aSAH requires a close cooperation between 
neurosurgeons, intensivists, cardiologists and radiologists in high volume centres. 
 
 
INTRODUCTION 
Cardiac dysfunction in patients with an intracranial pathology 
represents a well-known complication and a pressing problem for both 
neurosurgeons and intensivists treating such a patient. The matter is  
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probably best described for cases of subarachnoid 
hemorrhage (SAH), which account for approximately 
10% of all strokes. Most SAHs are caused by ruptured 
saccular (berry) aneurysms.  
This is a devastating clinical event, with a high 
mortality rate - average case fatality of 51%, as well 
as substantial neurologic morbidity in survivors (1-7).  
The complex interactions between the affected 
brain and the heart are responsible for unique 
cardiovascular morbidity and mortality - up to 23% of 
deaths caused by cardiovascular and pulmonary 
complications (1)(8)(9). A number of cardiac changes 
occur in the acute phase of SAH, including ECG 
changes, structural changes on echocardiography, 
and acute troponin and NT-proBNP elevations (3)(10-
16). 
 
CASE PRESENTATION 
A 47-year-old man, with a medical history of hyper-
tension, was brought to the emergency department 
in Pitesti for repetitive generalized seizures. Upon 
presentation, he had a Glasgow Coma Scale of 5 (E1, 
V1, M3), therefore he was sedated and intubated. His 
wife told the doctors that a few hours earlier he had 
complained of a severe headache, followed by a 
reduction in visual acuity for the left eye. Moreover, 
2 weeks back, he had presented another severe 
headache and vomiting. The head CT revealed an 
interhemispheric hemorrhage and a right-sided 
fronto-temporo-parietal subdural hematoma. The 
patient was then transferred to the University 
Emergency Hospital in Bucharest. Upon admission, 
he was sedated, with a GCS of 3, anisocoria 
(mydriasis of the right eye) and left hemiplegia; he 
was intubated and mechanically ventilated and 
cardiovascularly stable, with a normal ECG (Fig. 1). An 
emergency angiography revealed a ruptured 
aneurysm on the anterior communicating artery, 
which was embolized. The subdural hematoma was 
also evacuated. 
 
 
 
FIGURE 1. Normal ECG upon admission 
 
 
 
FIGURE 2. ST segment depression in the anterolateral territory (V2-V6) 
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FIGURE 3. Atrial flutter, with variable atrio-ventricular block, and antero-lateral ST depression 
 
 
 
 
FIGURE 4. T wave flattening in DII, DIII, aVF, V1-V2 and V6 
 
On the third day, the patient was neurologically 
better – a CGS of 8 (E2, V1, M5), maintaining left 
hemiplegia, yet still intubated and mechanically 
ventilated, with an arterial pressure of 105/65 
mmHg, tachycardic 108 bpm. His ECG started 
changing, at first with ST segment depression in V2-
V6 (antero-lateral territory), followed by atrial flutter, 
with variable atrioventricular block, and 
anterolateral ST depression (Fig. 2,3). Cardiac 
enzymes were also high – CK 807 U/L, CKMB 105 U/L, 
troponin I 1,5 ng/ml and NT-proBNP 173 pg/ml, with 
normal creatinine clearance and electrolytes. On 
echocardiography, there was a normal left 
ventricular ejection fraction and no wall-motion 
anomaly, thus the scenario was interpreted by the 
cardiologist as neurologically mediated. CK (1262 
U/L) and CKMB (203 U/L) reached their peak value 8 
hours later, while troponin had a maximum value of 
8,26 ng/ml approximately 20 hours later. 
A repeated head CT on day 5 revealed a frontal 
intraparenchymal hemorrhage of 55/14 mm in axial 
plane and 27 mm cranio-caudal and a bilateral 
frontal cortico-subcortical ischemic area in the 
vascularisation territory of the anterior cerebral 
artery. The vasospasm was confirmed by 2 
subsequent angiographies performed on day 5 and 
7, when Nimotop (nimodipine) was also locally 
injected.  
CK and CKMB normalized on day 5, while 
troponin I normalized on day 7. On day 36, the 
patient was conscious, with a CGS of 13-14 (E 4 V 3-4, 
M 6) and a residual left hemiparesis, spontaneously 
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breathing, cardiovascularly stable and a relatively 
normal ECG (T wave flattening in DII, DIII, aVF, V1-V2 
and V6) (Fig. 4). 
 
MATERIAL AD METHOD FOR THE LITERATURE REVIEW 
We queried the international database PubMed for 
recent articles using the syntax: subarachnoid 
[title/abstract], hemorrhage [title/abstract], cardiac 
[title/abstract], restricted with filters: publication 
date from 2012/01/01 to 2018/04/01; humans. 
Afterwards we selected 44 articles tackling the 
aspects of raised levels of troponin and NT-proBNP 
and ECG and echocardiography changes in patients 
with SAH. 
 
RESULTS  
Our analysis of the selected articles revealed that 22 
are patient population studies, 16 are case series and 
6 are reviews of the medical literature.  
 
ECG abnormalities 
Jeong et al., in a study of 122 patients with SAH and 
no previous heart disease (62% women) [17] aimed 
to determine the frequency, influencing factors and 
impact on outcome of cardiac arrhythmias after 
aSAH. 50% of their population had a clinically 
significant ECG change, the most common type being 
nonspecific ST-T changes. A multivariate analysis 
showed no significant association of various factors 
(age, sex, Hunt-Hess grade, Fisher grade, 
hypertension, symptomatic vasospasm and ICU 
length of stay) with clinically significant arrhythmia. 
Yet, the presence of ECG changes wasindependently 
predictive of death and poor outcome. On the other 
hand, July et al. (18) managed to demonstrate that 
ECG abnormalities were significantly associated with 
total cortisol an day 4 and free cortisol on day 2, while 
Amin et al. (19) observed a statistically significant 
association between SAH and QTc prolongation.  
Prolonged QT was the most prevalent ECG 
change in 413 patients from CONSCIOUS-1, a 
prospective randomized trial of clazosentran for the 
prevention of angiographic vasospasm (10). In this 
group of patients, the authors tried to identify ECG 
changes associated with angiographic vasospasm 
following SAH and concluded that, on multivariate 
analysis, QT prolongation and tachycardia are both 
associated with this complication. Moreover, 
tachycardia and ST changes were associated with 
worse clinical outcome. 
In another large prospective study - 447 SAH 
patients, Schmidt et al. (20) confirmed that 
uncontrolled prolonged heart rate elevation (PEHR) 
is associated with an increased risk of major 
cardiopulmonary events: hypertension and 
hypotension requiring vasoactive therapy, 
pulmonary edema, myocardial injury evidenced by 
troponin I elevation and poor outcome. 39% of their 
patients developed PEHR (heart rate of at least 95 
beats/minute, for more than 12 hours), with 68% of 
them having late-onset PEHR (more than 72 hours 
after SAH onset), which was correlated with an 
increased risk of delayed cerebral ischemia from 
cerebral vasospasm. Multifactorial logistic 
regression revealed the factors associated with 
PEHR: nonwhite race, Hunt-Hess score of at least 4 at 
admission, high admission APACHE-2 score and 
modified Fisher score. In this study, pre-hospital 
beta-blocker use was protective against PEHR. 
By contrast, in a retrospective review of 254 
patients with SAH, Crago et al. found (21) no 
relationship between the pre-hospital use of ACE 
inhibitors and/or beta-blockers and the 
development of pulmonary congestion, elevation in 
troponin or CKMB, heart rate, ECG changes or 
echocardiography findings. Moreover, a relationship 
was described between the use of these drugs and 
arrhythmias (ventricular or supraventricular) 
recorded by Holter monitoring, with patients taking 
beta-blockers. 
A study from Japan (22) draws attention on the 
clinical scenario of comatose patients resuscitated 
from SAH-associated out-of-hospital cardiac arrest 
(OHCA) (SAH-OHCA) who often have clinical signs 
that mimic acute coronary syndrome-associated 
OHCA (ACS-OHCA) patients. As the management of 
SAH is totally different from that for ACS, doctors 
should be able to differentiate between the two as 
quickly as possible. Yamashina et al.analysed the 
retrospective data of 1259 consecutive OHCA and 
included in their study 23 resuscitated comatose 
ACS-OHCA patients and 20 resuscitated comatose 
SAH-OHCA patients. ST-T abnormalities on the ECG 
suggesting myocardial damage were noted in most 
patients in both groups (95% in the ACS-OHCA and 
85% in SAH-OHCA), yet reciprocal ST depression was 
significantly more often absent in the SAH-OHCA 
group. Moreover, pulseless electrical activity (PEA) or 
asystole as the initial cardiac rhythm, female gender, 
and preserved left ventricular ejection fraction were 
 367 Cardiac dysfunction evoked by ECG and echocardiography changes and release of cardiac biomarkers 
significantly more common in the SAH-OHCA group. 
In their group, initial PEA/asystole and presence of 1 
other factor was sufficient to differentiate between 
SAH and ACS-OHCA patients (100% sensitivity, 91% 
specificity, 95% accuracy).  
Almost all the 16 case reports also point to the 
possibility of SAH masquerading as an ACS (23-36). 
One of them presents the scenario of SAH with the 
pattern of sinus node dysfunction on the ECG (37), 
while Elsharkawy et al., on a cohort of 20 SAH 
patients observed that patients with fluctuating ECG 
changes had a poor outcome compared with 
patients with fixed abnormalities (38). 
 
Troponin and NT-proBNP elevation 
In a retrospective review of 617 patients with aSAH 
conducted by Ahmadian et al. (13), 14.1% (87 
patients) required a cardiac evaluation: 63% had 
arrhythmia, 47% suffered a myocardial infarction 
and 31% developed heart failure. The majority of 
cases with a myocardial infarction (90.2%) were non-
ST elevation MI, while atrial fibrillation was the most 
common form of tachyarrhythmia described. Among 
the patients who had a cardiac event at the time of a 
SAH, those with myocardial infarction, and in 
particular those with a troponin level greater than 1 
mcg/L had a 10 times higher risk of death. 
Oras et al. (11), in a single-centre prospective 
observational study including 126 SAH patients, 
managed to conclude that both peak levels of 
troponin (hsTnT in their study) and NT-proBNP are 
independently associated with cerebral infarction 
due to delayed cerebral ischemia. hsTnT had its peak 
level at admission followed by a daily decline; by 
contrast, NT-proBNP had lowest levels on day 1 after 
SAH and increased on days 2 to 4. Moreover, age, 
poor neurological status upon admission, cerebral 
infarction and peak hsTnT were independently 
associated with poor late outcome.  
The area under the curve (AUC) for the first 4 days 
was used by Nyberg et al. (39) to quantitatively 
measure the BNP load during the first critical part of 
the disease in 138 patients with a SAH. A more severe 
SAH defined by a higher Fisher and World of 
Neurosurgical Societies grade, neurological deficits, 
an aneurysm, infections or higher levels of troponin 
I at admission had a larger AUC for NT-proBNP. 
Women, older people and those with poor outcomes 
also had larger AUC for NT-proBNP.  
Terao et al. (40) investigated the relationship 
between urinary albumin/creatinine ratio (ACR), NT-
proBNP level and neurological outcome after SAH in 
61 patients. NT-proBNP highest levels were above 
normal limits in 93% patients, while 85% of them 
developed microalbuminuria. The study 
demonstrated on the one hand that the peak value 
of NT-proBNP was significantly associated with peak 
troponinI value and highest ACR. On the other hand, 
peak ACR and Hunt-Hess grade were independent 
predictors of poor neurological outcome. 
 
Neurogenic myocardial stunning 
Prunet et al (3)(41) evaluated cardiac glucose 
metabolism and myocardial perfusion and assessed 
the duration and reversibility of cardiac sympathetic 
impairment after SAH in 30 hemodynamically stable 
acute phase SAH patients, by using F-
fluorodesoxyglucose positron emission tomography 
(18F-FDGPET), 99mTc-tetrofosmin and 123I-meta-
iodobenzylguanidine (123I-mIBG). 83% revealed initial 
impairment of cardiac glucose metabolism and the 
defect pattern could not be explained by a single 
coronary artery distribution, while 90% exhibited 
initial impairment of cardiac sympathetic 
innervation. All patients had normal myocardial 
perfusion and normal left ventricular systolic 
function. There was a concordance of 123I-mIBG and 
18F-FDG uptake abnormalities, as well as a common 
temporal evolution, which suggests the close 
relationship between myocardial sympathetic 
function and glucose metabolism; yet neither of 
them produced left ventricular systolic or diastolic 
dysfunction in this group of patients (41). 
In a group of 300 ash patients, Malik et al. (42) 
tried to determine the risk factors for the occurrence 
of neurogenic stress cardiomyopathy (NSC), which 
they defined as having at least one of the following: 
ECG changes (long OQ, T wave inversions), troponin 
level higher than 0.1 or decreased ejection fraction 
and wall motion abnormalities on the 
echocardiogram. After a multivariate analysis, they 
concluded that higher Hunt-Hess grade on 
admission, smoking, older age and lack of 
hypertension were the strongest predictors of NSC. 
In a larger group of 715 SAH patients, Bihorac et 
al. (43), aimed to compare short- and long-term 
outcomes in patients with different patterns of 
regional left ventricular dysfunction (RLVD) as a 
manifestation of stress-induced cardiomyopathy 
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after SAH. 28% (200 patients) of these patients had 
an echocardiogram for clinical evidence of cardiac 
dysfunction, 30% of whom (59 patients) had RLVD. 
The observation was that the risk of death was 
significantly higher in patients who need an 
echocardiogram in the first place, regardless of the 
presence or absence of RLVD on that 
echocardiogram.  
 
 
CONCLUSION 
SAH should probably be the most feared type of 
stroke event among clinicians. On the one hand, it 
affects younger adults and individuals in their prime, 
therefore the individual disability burden and 
consequential social impact is devastating. On the 
other hand, SAH is a multisystem disease, and 
medical complications have been identified as 
factors that can contribute to worse outcomes, 
thereby awareness of this fact is warranted. 
Cardiac abnormalities are common after SAH, 
even in non coronary-disease patients. Clinically 
significant arrhythmias after SAH are associated with 
a high mortality rate, as well as serious cardiac and 
neurological comorbidities[17]. These patients 
should be submitted to a close cardiac monitoring. 
Some patients (20-30%) present with acute 
cardiac enzyme elevation, and an increase in 
troponin I, which occurs in more severe patients, 
correlates with poor long-term outcome. Increased 
levels of troponin, but also NT-proBNP, upon 
admission are both independently associated with 
delayed cerebral ischemia (11)(12). Troponin I and 
NT-proBNP elevation should therefore be early 
detected and closely monitored and those patients 
timely managed by a multidisciplinary team of 
doctors (44). 
We should also bear in mind the fact that cardiac 
alterations associated with SAH include both systolic 
and diastolic dysfunction of the left ventricle, and 
that, in order to prevent pulmonary and other organ 
congestion due to heart dysfunction, it is strongly 
advised to perform echocardiography on admission 
of a SAH patient, and to repeatedly monitor this way 
a patient with SAH and RLVD during the triple H 
therapy (2)(14)(34)(36). 
For comatose OHCA resuscitated patients, initial 
ED evaluation might be sufficient to differentiate 
between an ACS or a SAH as the cause of the cardiac 
arrest, prior to further, time consuming tests (22). 
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